Cited by 357Endometriosis Research and TreatmentMicroRNA in disease regulationExtracellular vesicles in disease

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.

MicroRNA-Regulated Pathways Associated with Endometriosis

Open access
Ohlsson Teague, E. Maria C., Van der Hoek, Kylie H., Van der Hoek, Mark B., Perry, Naomi, Wagaarachchi, Prabhath, Robertson, Sarah A., Print, Cristin G., Hull, Louise M.·2009·Molecular Endocrinology

Abstract

Endometriosis is a prevalent gynecological disease characterized by growth of endometriotic tissue outside the uterine cavity. MicroRNAs (miRNAs) are naturally occurring posttranscriptional regulatory molecules that potentially play a role in endometriotic lesion development. We assessed miRNA expression by microarray analysis in paired ectopic and eutopic endometrial tissues and identified 14 up-regulated (miR-145, miR-143, miR-99a, miR-99b, miR-126, miR-100, miR-125b, miR-150, miR-125a, miR-223, miR-194, miR-365, miR-29c and miR-1) and eight down-regulated (miR-200a, miR-141, miR-200b, miR-142-3p, miR-424, miR-34c, miR-20a and miR-196b) miRNAs. The differential expression of six miRNAs was confirmed by quantitative RT-PCR. An in silico analysis identified 3851 mRNA transcripts as putative targets of the 22 miRNAs. Of these predicted targets, 673 were also differentially expressed in ectopic vs. eutopic endometrial tissue, as determined by microarray. Functional analysis suggested that the 673 miRNA targets constitute molecular pathways previously associated with endometriosis, including c-Jun, CREB-binding protein, protein kinase B (Akt), and cyclin D1 (CCND1) signaling. These pathways appeared to be regulated both transcriptionally as well as by miRNAs at posttranscriptional level. These data are a rich and novel resource for endometriosis and miRNA research and suggest that the 22 miRNAs and their cognate mRNA target sequences constitute pathways that promote endometriosis. Accordingly, miRNAs are potential therapeutic targets for treating this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/me.2008-0387

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Flagged first, then by citations

Show all 65 references

1 of the 65 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 101–200 of 357

Metadata

Authors
Ohlsson Teague, E. M. C., Van der Hoek, K. H., Van der Hoek, M. B., Perry, N., Wagaarachchi, P., Robertson, S. A., Print, C. G., & Hull, L. M.
Affiliations
  • The University of Adelaide (AU)
  • Women's and Children's Hospital (AU)
  • University of Auckland (NZ)
Venue
Molecular Endocrinology
Published
2009-02
Volume
23
Issue
2
Pages
265-275
ISSN
  • 0888-8809 (ISSN-L)
  • 1944-9917
OpenAlex
W1993162436
Cited by
357
References
65
Citations by year
2026: 4 · 2025: 16 · 2024: 17 · 2023: 11 · 2022: 24 · 2021: 21 · 2020: 22 · 2019: 22 · 2018: 26 · 2017: 25 · 2016: 23 · 2015: 22 · 2014: 20 · 2013: 25 · 2012: 18
FWCI
23.24
Type
journal article
Language
en
Open access
Locations
  • Molecular Endocrinology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • ResearchSpace (University of Auckland) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords
endometriosis, microRNA, miRNA expression profiling, ectopic endometrium, eutopic endometrium, miRNA target prediction, CREB-binding protein, Akt signaling, cyclin D1, post-transcriptional regulation, therapeutic target
MeSH terms
Endometriosis, Female, Gene Expression Regulation, Multigene Family, Humans, Molecular Sequence Data, Signal Transduction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, MicroRNAs, JNK Mitogen-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review